Leigh G. Seamon

2.5k total citations
49 papers, 1.8k citations indexed

About

Leigh G. Seamon is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Leigh G. Seamon has authored 49 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Reproductive Medicine, 24 papers in Obstetrics and Gynecology and 17 papers in Surgery. Recurrent topics in Leigh G. Seamon's work include Endometrial and Cervical Cancer Treatments (24 papers), Ovarian cancer diagnosis and treatment (24 papers) and Uterine Myomas and Treatments (13 papers). Leigh G. Seamon is often cited by papers focused on Endometrial and Cervical Cancer Treatments (24 papers), Ovarian cancer diagnosis and treatment (24 papers) and Uterine Myomas and Treatments (13 papers). Leigh G. Seamon collaborates with scholars based in United States, Iran and Spain. Leigh G. Seamon's co-authors include David E. Cohn, Jeffrey M. Fowler, Gary Phillips, Debra L. Richardson, Matthew J. Carlson, Iwona Podzielinski, Christopher P. DeSimone, S. Goodrich, John R. van Nagell and David M. O’Malley and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and British Journal of Cancer.

In The Last Decade

Leigh G. Seamon

44 papers receiving 1.8k citations

Peers

Leigh G. Seamon
Bengt Tholander Sweden
Patrick Neven Belgium
E. A. Eisenhauer Canada
Lisa Barroilhet United States
Şennur İlvan Türkiye
Jérôme Alexandre France
Yuko Sugiyama Japan
Aliza Leiser United States
Chongdong Liu China
Ida Paris Italy
Bengt Tholander Sweden
Leigh G. Seamon
Citations per year, relative to Leigh G. Seamon Leigh G. Seamon (= 1×) peers Bengt Tholander

Countries citing papers authored by Leigh G. Seamon

Since Specialization
Citations

This map shows the geographic impact of Leigh G. Seamon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leigh G. Seamon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leigh G. Seamon more than expected).

Fields of papers citing papers by Leigh G. Seamon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leigh G. Seamon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leigh G. Seamon. The network helps show where Leigh G. Seamon may publish in the future.

Co-authorship network of co-authors of Leigh G. Seamon

This figure shows the co-authorship network connecting the top 25 collaborators of Leigh G. Seamon. A scholar is included among the top collaborators of Leigh G. Seamon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leigh G. Seamon. Leigh G. Seamon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Papadopoulos, Kyriakos P., Manish Sharma, Reinhard Dummer, et al.. (2024). Results of a phase 1, dose-finding study of Debio 0123 as monotherapy in adult patients with advanced solid tumors: Safety, pharmacokinetic, and preliminary antitumor activity data.. Journal of Clinical Oncology. 42(16_suppl). 3120–3120. 5 indexed citations
3.
Lee, Eric, Oladapo Yeku, Ira Winer, et al.. (2024). 719MO A phase I/II study of rinatabart sesutecan (Rina-S) in patients with advanced ovarian or endometrial cancer. Annals of Oncology. 35. S550–S550. 3 indexed citations
4.
5.
Kim, Hong Im, Chad R. Schultz, Andrea L. Buras, et al.. (2017). Ornithine decarboxylase as a therapeutic target for endometrial cancer. PLoS ONE. 12(12). e0189044–e0189044. 36 indexed citations
6.
Baldwin, Lauren, Bin Huang, Rachel W. Miller, et al.. (2012). Ten-Year Relative Survival for Epithelial Ovarian Cancer. Obstetrics and Gynecology. 120(3). 612–618. 263 indexed citations
7.
Quick, Allison, Leigh G. Seamon, Mahmoud Abdel‐Rasoul, Ritu Salani, & Douglas Martin. (2012). Sexual Function After Intracavitary Vaginal Brachytherapy for Early-Stage Endometrial Carcinoma. International Journal of Gynecological Cancer. 22(4). 703–708. 29 indexed citations
8.
Fader, Amanda N., Leigh G. Seamon, Pedro F. Escobar, et al.. (2012). Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: A multi-site study performed at high volume cancer centers. Gynecologic Oncology. 126(2). 180–185. 82 indexed citations
9.
Podzielinski, Iwona, Marcus E. Randall, Patrick Breheny, et al.. (2011). Primary radiation therapy for medically inoperable patients with clinical stage I and II endometrial carcinoma. Gynecologic Oncology. 124(1). 36–41. 51 indexed citations
10.
Baldwin, Lauren, Iwona Podzielinski, S. Goodrich, & Leigh G. Seamon. (2011). Robotic surgery for adnexal masses in pregnancy. Journal of Robotic Surgery. 5(3). 231–233. 1 indexed citations
11.
Zhang, Zhaoxia, Thomas J. Knobloch, Leigh G. Seamon, et al.. (2011). A black raspberry extract inhibits proliferation and regulates apoptosis in cervical cancer cells. Gynecologic Oncology. 123(2). 401–406. 36 indexed citations
12.
Ueland, Frederick R., Christopher P. DeSimone, Leigh G. Seamon, et al.. (2011). Effectiveness of a Multivariate Index Assay in the Preoperative Assessment of Ovarian Tumors. Obstetrics and Gynecology. 117(6). 1289–1297. 173 indexed citations
13.
Seamon, Leigh G., Jeffrey M. Fowler, & David E. Cohn. (2010). Lymphadenectomy for endometrial cancer: The controversy. Gynecologic Oncology. 117(1). 6–8. 38 indexed citations
14.
Bakkum‐Gamez, Jamie N., Debra L. Richardson, Leigh G. Seamon, et al.. (2010). Is There a High-Risk Subgroup of Stage I Epithelial Ovarian Cancer That Is Most Likely to Benefit From 6 Versus 3 Cycles of Adjuvant Chemotherapy?. International Journal of Gynecological Cancer. 20(7). 1125–1131. 5 indexed citations
15.
Podzielinski, Iwona, Rachel Ware, S. Goodrich, et al.. (2010). Risk of malignancy in sonographically confirmed septated cystic ovarian tumors. Gynecologic Oncology. 118(3). 278–282. 32 indexed citations
16.
Seamon, Leigh G., et al.. (2009). Paratubal borderline serous tumors. Gynecologic Oncology. 113(1). 83–85. 18 indexed citations
17.
Rasool, Nabila, Amanda N. Fader, Leigh G. Seamon, et al.. (2009). Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: An analysis of clinical outcomes and patterns of recurrence. Gynecologic Oncology. 116(1). 10–14. 42 indexed citations
18.
Seamon, Leigh G., Matthew J. Carlson, Debra L. Richardson, et al.. (2009). Outpatient Platinum-Taxane Intraperitoneal Chemotherapy Regimen for Ovarian Cancer. International Journal of Gynecological Cancer. 19(7). 1195–1198. 8 indexed citations
19.
Richardson, Debra L., Leigh G. Seamon, Matthew J. Carlson, et al.. (2008). CA125 decline in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy. Gynecologic Oncology. 111(2). 233–236. 12 indexed citations
20.
Cohn, David E., Nathan C. Hall, Stephen P. Povoski, et al.. (2008). Novel perioperative imaging with 18F-FDG PET/CT and intraoperative 18F-FDG detection using a handheld gamma probe in recurrent ovarian cancer. Gynecologic Oncology. 110(2). 152–157. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bengt Tholander Breakdown of academic impact, for papers by Patrick Neven Breakdown of academic impact, for papers by E. A. Eisenhauer Breakdown of academic impact, for papers by Lisa Barroilhet Breakdown of academic impact, for papers by Şennur İlvan Breakdown of academic impact, for papers by Jérôme Alexandre Breakdown of academic impact, for papers by Yuko Sugiyama Breakdown of academic impact, for papers by Aliza Leiser Breakdown of academic impact, for papers by Chongdong Liu Breakdown of academic impact, for papers by Ida Paris
Rankless by CCL
2026